Barclays PLC Biote Corp. Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Biote Corp. stock. As of the latest transaction made, Barclays PLC holds 77,378 shares of BTMD stock, worth $311,833. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,378
Previous 77,196
0.24%
Holding current value
$311,833
Previous $432,000
10.42%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BTMD
# of Institutions
91Shares Held
18.6MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$18.3 Million12.7% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$9.82 Million5.9% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$6.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$5.76 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.35MShares$5.45 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $30.5M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...